Andere talen Plandaí Biotechnology, Inc.

Aandelen

PLPL

US72703D1000

Vertraagde tijd OTC Markets Andere beurzen 21:47:50 20-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0004 ^USD	-20,00%		0,00%	+100,00%

2023	Plandaí Biotechnology, Inc. heeft de overname van ByoPlanet International, LLC geannuleerd.	CI
2023	Rick O'Shea wordt CEO van Plandaí Biotechnology, Inc.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC.	01-08-23
CapitalGainsReport: Penny Stock Breakout Watchlist (EPAZ, DPLS, PLPL, BDPT)	30-06-23
Sub-Penny Spotlight (HBRM, PLPL, CNNA, AITX)	26-05-23
Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health	19-05-23
CapitalGainsReport: News Catalysts Could Send These Stocks Soaring (EPAZ, GGSM, KYNC, PLPL)	19-05-23
Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc	17-05-23
Plandaí Biotechnology, Inc. entered into share exchange agreement to acquire ByoPlanet International, LLC.	17-05-23
PLANDAI BIOTECHNOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-03-23
PLANDAI BIOTECHNOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	16-03-23
EV Hotel Corp. terminated the acquisition of Plandaí Biotechnology, Inc. in a reverse merger transaction.	04-01-23
EV Hotel Corp. entered into non-binding letter of intent to acquire Plandaf Biotechnology, Inc. in a reverse merger transaction.	06-10-22
Plandaí Biotechnology : Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent	27-07-22
Plandaí Biotechnology : SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action	22-06-22
Plandaí Biotechnology : Plandai Biotechnology, Inc. Reinstated	11-11-20
Plandai Biotechnology Provides Comment on SEC Action	23-08-18
Plandaí Biotechnology Announces Successful Completion of Government Inspection of Affiliate Protext Pharma’s Proposed Medical Cannabis Facility	17-07-18
Plandai Biotechnology Exploring Opportunities in the U.S. Poultry Market	03-07-18
Plandaí Biotechnology to Focus on International Nutraceutical Cannabis Opportunities	19-06-18
Plandai Biotechnology Discusses Cannabis Extract Opportunities and Research Potential	14-06-18
Plandai Biotechnology Discusses Potential for Using Phytofare in Treating Type II Diabetes	12-06-18

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Plandaí Biotechnology, Inc.

Aandelen

PLPL

US72703D1000

Andere talen

Filters